The genetics of pyoderma gangrenosum and implications for treatment: A systematic review

British Journal of Dermatology

Volumn 172, Issue 6, 2015, Pages 1487-1497

  Defilippis, E M ^a   Feldman, S R ^a   Huang, W W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANGIOGENESIS INHIBITOR; ANTIBIOTIC AGENT; AZATHIOPRINE; CYANOCOBALAMIN; ETANERCEPT; FOLIC ACID; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; JANUS KINASE; JANUS KINASE 2; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; PYRIDOXINE; RUXOLITINIB; STEROID; THALIDOMIDE; VITAMIN B GROUP; JAK2 PROTEIN, HUMAN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ANTIBIOTIC THERAPY; AUTOSOMAL RECESSIVE INHERITANCE; BACTERIAL ARTHRITIS; BIOLOGICAL THERAPY; COCHRANE LIBRARY; DISEASE ASSOCIATION; FAMILIAL DISEASE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; INFLAMMATORY BOWEL DISEASE; MEDLINE; MYELODYSPLASTIC SYNDROME; PAPA SYNDROME; POLYARTHRITIS; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; SYSTEMIC DISEASE; ACNE VULGARIS; ARTHRITIS; CHILD; COMPLICATION; FORECASTING; GENETICS; IRRITABLE COLON; MUTATION; PRESCHOOL CHILD;

ACNE VULGARIS; ARTHRITIS; CHILD; CHILD, PRESCHOOL; FORECASTING; HEMATOLOGIC DISEASES; HUMANS; IRRITABLE BOWEL SYNDROME; JANUS KINASE 2; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; PYODERMA GANGRENOSUM;

EID: 84930349675     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13493     Document Type: Review

References (212)

1. Ahronowitz I, Harp J, Shinkai K,. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol 2012; 13: 191-211.
2. Weizman A, Huang B, Berel D, et al,. Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients. Inflamm Bowel Dis 2014; 20: 525-33.
3. Bhat RM, Nandakishore B, Sequeira FF, et al,. Pyoderma gangrenosum: an Indian perspective. Clin Exp Dermatol 2011; 36: 242-7.
4. Vavricka SR, Brun L, Ballabeni P, et al,. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2011; 106: 110-19.
5. Wasmuth HH, Tranø G, Endreseth BH, et al,. Primary sclerosing cholangitis and extraintestinal manifestations in patients with ulcerative colitis and ileal pouch-anal anastomosis. J Gastrointest Surg 2010; 14: 1099-104.
6. Moravvej H, Razavi GM, Farshchian M, Malekzadeh R,. Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study. Indian J Dermatol Venereol Leprol 2008; 74: 607-10.
7. McCallum DI, Kinmont PD,. Dermatological manifestations of Crohn's disease. Br J Dermatol 1968; 80: 1-8.
8. Johnson ML, Wilson HT,. Skin lesions in ulcerative colitis. Gut 1969; 10: 255-63.
9. O'Loughlin S, Perry HO,. A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol 1978; 114: 1061-4.
10. Hickman JG, Lazarus GS,. Pyoderma gangrenosum: a reappraisal of associated systemic diseases. Br J Dermatol 1980; 102: 235-7.
11. Omidi CJ, Siegfried EC,. Chronic recurrent multifocal osteomyelitis preceding pyoderma gangrenosum and occult ulcerative colitis in a pediatric patient. Pediatr Dermatol 1998; 15: 435-8.
12. Yamasaki O, Iwatsuki K, Kaneko F,. A case of SAPHO syndrome with pyoderma gangrenosum and inflammatory bowel disease masquerading as Behçet's disease. Adv Exp Med Biol 2003; 528: 339-41.
13. Khurrum Baig M, Marquez H, Nogueras JJ, et al,. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases. Colorectal Dis 2004; 6: 250-3.
14. Ozdil S, Akyüz F, Pinarbasi B, et al,. Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?). Hepatogastroenterology 2004; 57: 768-70.
15. Lipka S, Katz S, Ginzburg L,. Massive pyoderma gangrenosum in a 77 year old female with Crohn's disease responsive to adalimumab. J Crohns Colitis 2013; 7: 427-8.
16. Tanaka K, Araki T, Okita Y, et al,. Pyoderma gangrenosum occurring at the peri-ileal pouch-anal anastomosis in a patient with ulcerative colitis: report of a case. Surg Today 2014; 44: 783-5.
17. Stair-Buchmann ME, Ackerman BH, Reigart CL, et al,. Pyoderma gangrenosum: a difficult diagnosis best managed in a burn treatment center. J Burn Care Res 2014; DOI: 10.1097/BCR.0000000000000119 [Epub ahead of print].
18. Sheldon DG, Sawchuk LL, Kozarek RA, Thirlby RC,. Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management. Arch Surg 2000; 135: 564-8.
19. Rustagi T,. Three decades later: pyoderma gangrenosum and episcleritis in a patient with quiescent ulcerative colitis. Conn Med 2014; 78: 221-3.
20. Goreti Catorze M, Pereira F, Fonseca F, et al,. Pyoderma gangrenosum associated with sclerosing cholangitis, type 1 diabetes mellitus and ulcerative colitis. J Eur Acad Dermatol Venereol 2001; 15: 257-9.
21. Goldberg I, Finkel O, Gat A, et al,. Concomitant occurrence of pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease. Isr Med Assoc J 2014; 16: 168-70.
22. Li X, Chandra S,. A case of ulcerative colitis presenting as pyoderma gangrenosum and lung nodule. J Community Hosp Intern Med Perspect 2014; 4: 23402.
23. Felton S, Al-Niaimi F, Lyon C,. Severe back pain in a young patient with pyoderma gangrenosum and Crohn's disease controlled with anti-tumor necrosis factor therapy: sterile osteomyelitis. Dermatol Ther 2014; 4: 137-40.
24. Sharma P, Dhungel S,. All that is red is not cellulitis. Pyoderma gangrenosum. Eur J Intern Med 2014; 25: e17-18.
25. Satoh M, Yamamoto T,. Genital pyoderma gangrenosum: report of two cases and published work review of Japanese cases. J Dermatol 2013; 40: 840-3.
26. Visrodia K, Shivashankar R, Oxentenko AS,. A young woman with odynophagia, diarrhea, and perineal ulcerations. Crohn's disease, pyoderma gangrenosum, and E. coli bacteremia. Gastroenterology 2013; 145: 517.
27. Guo H, Zhang L, An Q, et al,. Pyoderma gangrenosum associated with ulcerative colitis and psoriasis. Chin Med J (Engl) 2013; 126: 1798.
28. Patvekar MA, Virmani NC,. Pyoderma gangrenosum with an underlying ulcerative colitis associated with bone tuberculosis. Indian Dermatol Online J 2013; 4: 43-6.
29. Batres LA, Mamula P, Baldassano RN,. Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn disease. J Pediatr Gastroenterol Nutr 2002; 34: 558-60.
30. Sapienza MS, Cohen S, Dimarino AJ,. Treatment of pyoderma gangrenosum with infliximab in Crohn's disease. Dig Dis Sci 2004; 49: 1454-7.
31. Freeman HJ,. Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease. Can J Gastroenterol 2005; 19: 603-6.
32. Tuncer C, Mutluay R, Ayyildiz T,. Crohn's colitis with extraintestinal manifestations: a case report. Turk J Gastroenterol 2002; 13: 66-9.
33. Kouklakis G, Zezos P, Liratzopoulos N, et al,. Billroth II gastrectomy complicated by gastrojejunocolonic fistulas, treated endoscopically with a cardiac septal defect closure device. Endoscopy 2010; 42 (Suppl. 2): E134-5.
34. Andrade P, Brites MM, Figueiredo A,. Synchronous pyoderma gangrenosum and inflammatory bowel disease, healing after total proctocolectomy. An Bras Dermatol 2012; 87: 637-9.
35. Andrisani G, Guidi L, Papa A, et al,. A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery. J Crohns Colitis 2013; 7: 421-6.
36. Triantafillidis JK, Cheracakis P, Sklavaina M, Apostolopoulou K,. Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum. Scand J Gastroenterol 2002; 37: 863-5.
37. Ben Chaabane N, Hellara O, Ben Mansour W, et al,. Auricular pyoderma gangrenosum associated with Crohn's disease. Tunis Med 2012; 90: 414-15.
38. Langan SM, Groves RW, Card TR, Gulliford MC,. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol 2012; 132: 2166-70.
39. Carrasco Cubero C, Ruiz Tudela MM, Salaberri Maestrojuan JJ, Pérez Venegas JJ,. Pyoderma gangrenosum associated with inflammatory bowel disease. Report of two cases with good response to infliximab. Reumatol Clin 2012; 8: 90-2.
40. Sinagra E, Orlando A, Renna S, et al,. Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin. Inflamm Bowel Dis 2012; 18: E1594-5.
41. Hayashi H, Kuwabara C, Tarumi K, et al,. Successful treatment with infliximab for refractory pyoderma gangrenosum associated with inflammatory bowel disease. J Dermatol 2012; 39: 576-8.
42. Cariñanos I, Acosta MB-D, Domènech E,. Adalimumab for pyoderma gangrenosum associated with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: E153-4.
43. Vornehm ND, Kelley SR, Ellis BJ,. Parastomal small bowel evisceration as a result of parastomal pyoderma gangrenosum in a patient with Crohn's disease. Am Surg 2011; 77: E150-1.
44. Saracino A, Kelly R, Liew D, Chong A,. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up. Australas J Dermatol 2011; 52: 218-21.
45. Binus AM, Qureshi AA, Li VW, Winterfield LS,. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol 2011; 165: 1244-50.
46. Franco S, Foresta G, Pulvirenti E, Giannone G,. Ulcerative colitis complicated by atypical peristomal pyoderma gangrenosum. Inflamm Bowel Dis 2011; 17: E111-12.
47. Tao W, Tao Q, Yue-Hua L,. Superficial granulomatous pyoderma accompanied with ulcerative colitis successfully treated with tacrolimus ointment. J Dermatol 2011; 38: 1105-8.
48. Polcz M, Gu J, Florin T,. Pyoderma gangrenosum in inflammatory bowel disease: the experience at Mater Health Services' Adult Hospital 1998-2009. J Crohns Colitis 2011; 5: 148-51.
49. Lee JI, Park HJ, Lee JY, Cho BK,. A case of pyoderma gangrenosum with ulcerative colitis treated with mesalazine. Ann Dermatol 2010; 22: 422-5.
50. Ho SA, Tan WP, Tan AW, et al,. Scrotal pyoderma gangrenosum associated with Crohn's disease. Singapore Med J 2009; 50: e397-400.
51. Selvapatt N, Barry J, Roberts PR,. Pyoderma gangrenosum complicating an implantable cardioverter defibrillator wound in a patient with ulcerative colitis. Europace 2009; 11: 1482.
52. Mancini GJ, Floyd L, Solla JA,. Parastomal pyoderma gangrenosum: a case report and literature review. Am Surg 2002; 68: 824-6.
53. Zold E, Nagy A, Devenyi K, et al,. Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: two birds with one stone. World J Gastroenterol 2009; 15: 2293-5.
54. Castro-Fernández M, Sánchez-Muñoz D, Ruíz-Granados E, et al,. Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis. Am J Gastroenterol 2007; 102: 2865-6.
55. Castro-Durán J, Martín-Armada M, Jiménez-Alonso J,. Pyoderma gangrenosum induced by acupuncture in a patient with ulcerative colitis. Arch Intern Med 2000; 160: 2394.
56. Ermis F, Ozdil S, Akyüz F, et al,. Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis. Inflamm Bowel Dis 2008; 14: 1611-13.
57. Ljung T, Staun M, Grove O, et al,. Pyoderma gangrenosum associated with Crohn disease: effect of TNF-alpha blockade with infliximab. Scand J Gastroenterol 2002; 37: 1108-10.
58. Grange F, Djilali-Bouzina F, Weiss AM, et al,. Corticosteroid-resistant pyoderma gangrenosum associated with Crohn's disease: rapid cure with infliximab. Dermatology 2002; 205: 278-80.
59. Warner BW,. Peristomal pyoderma gangrenosum. Gastroenterology 2000; 119: 873-4.
60. Friedman S, Marion JF, Scherl E, et al,. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease. Inflamm Bowel Dis 2001; 7: 1-7.
61. Ferkolj I, Hocevar A, Golouh R, Dolenc Voljc M,. Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease. Acta Dermatovenerol Alp Pannonica Adriat 2006; 15: 173-7.
62. Juillerat P, Christen-Zäch S, Troillet F-X, et al,. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review. Dermatology 2007; 215: 245-51.
63. Cocco A, Angelucci E, Viscido A, Caprilli R,. Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13: 1317-19.
64. Futami H, Kodaira M, Furuta T, et al,. Pyoderma gangrenosum complicating ulcerative colitis: successful treatment with methylprednisolone pulse therapy and cyclosporine. J Gastroenterol 1998; 33: 408-11.
65. Ljubojevic S, Milavec-Puretic V, Sredoja-Tisma V, et al,. Pyoderma gangrenosum associated with ulcerative colitis. Acta Dermatovenerol Croat 2006; 14: 35-9.
66. Von Tirpitz C, Buchwald HJ, Lang GK, et al,. Simultaneous onset of pyoderma gangrenosum and bitemporal abscesses of the upper eyelids during a flare of ulcerative colitis. Inflamm Bowel Dis 1998; 4: 98-100.
67. Borum ML, Cannava M, Myrie-Williams C,. Refractory, disfiguring vulvar pyoderma gangrenosum and Crohn's disease. Dig Dis Sci 1998; 43: 720-2.
68. Carp JM, Onuma E, Das K, Gottlieb AB,. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease. Cutis 1997; 60: 135-8.
69. Brennecke A,. Peristomal pyoderma gangrenosum: review and case study. Medsurg Nurs 1996; 5: 195-8.
70. Levitt MD, Ritchie JK, Lennard-Jones JE, Phillips RK,. Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg 1991; 78: 676-8.
71. Lilford RJ, Tindall VR, Batchelor AG,. Post-surgical pyoderma gangrenosum of the vaginal vault associated with ulcerative colitis and Behçet's disease; a case report. Eur J Obstet Gynecol Reprod Biol 1989; 31: 93-4.
72. Cave DR, Burakoff R,. Pyoderma gangrenosum associated with ulcerative colitis: treatment with disodium cromoglycate. Am J Gastroenterol 1987; 82: 802-4.
73. Holmlund DE, Wählby L,. Pyoderma gangrenosum after colectomy for inflammatory bowel disease. Case report. Acta Chir Scand 1987; 153: 73-4.
74. Cox NH, Peebles-Brown DA, MacKie RM,. Pyoderma gangrenosum occurring 10 years after proctocolectomy for ulcerative colitis. Br J Hosp Med 1986; 36: 363.
75. Barnes L, Lucky AW, Bucuvalas JC, Suchy FJ,. Pustular pyoderma gangrenosum associated with ulcerative colitis in childhood. Report of two cases and review of the literature. J Am Acad Dermatol 1986; 15: 608-14.
76. Galun E, Flugelman MY, Rachmilewitz D,. Pyoderma gangrenosum complicating ulcerative colitis: successful treatment with methylprednisolone pulse therapy and dapsone. Am J Gastroenterol 1986; 81: 988-9.
77. Mir-Madjlessi SH, Taylor JS, Farmer RG,. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol 1985; 80: 615-20.
78. McCulloch AJ, McEvoy A, Jackson JD, Jarvis EH,. Severe steroid responsive pneumonitis associated with pyoderma gangrenosum and ulcerative colitis. Thorax 1985; 40: 314-15.
79. Callen JP, Woo TY,. Vesiculopustular eruption in a patient with ulcerative colitis. Pyoderma gangrenosum. Arch Dermatol 1985; 121: 399.
80. Benton EC, Rutherford D, Hunter JA,. Sweet's syndrome and pyoderma gangrenosum associated with ulcerative colitis. Acta Derm Venereol 1985; 65: 77-80.
81. McGarity WC, Robertson DB, McKeown PP, et al,. Pyoderma gangrenosum at the parastomal site in patients with Crohn's disease. Arch Surg 1984; 119: 1186-8.
82. Smith EH, Essop AR, Segal I, Posen J,. Pyoderma gangrenosum and ulcerative colitis in black South Africans. Case reports. S Afr Med J 1984; 66: 341-3.
83. Gellert A, Green ES, Beck ER, Ridley CM,. Erythema nodosum progressing to pyoderma gangrenosum as a complication of Crohn's disease. Postgrad Med J 1983; 59: 791-3.
84. Schoetz DJ, Coller JA, Veidenheimer MC,. Pyoderma gangrenosum and Crohn's disease. Eight cases and a review of the literature. Dis Colon Rectum 1983; 26: 155-8.
85. Korelitz BI, Sommers SC,. Pyoderma gangrenosum complicating Crohn's disease. Am J Gastroenterol 1977; 68: 171-6.
86. McGarity WC, Barnett SM,. Pyoderma gangrenosum in Crohn's disease: report of a case. Dis Colon Rectum 1977; 20: 49-52.
87. Greenstein AJ, Janowitz HD, Sachar DB,. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976; 55: 401-12.
88. Kiel VL,. Pyoderma gangrenosum in ulcerative colitis; report of a case. Arch Derm Syphilol 1947; 56: 187-90.
89. Cole HN, Driver JR,. Pyoderma gangrenosum associated with nonspecific ulcerative colitis. Arch Derm Syphilol 1945; 52: 416.
90. McIver MA, Lucas V,. Pyoderma gangrenosum; a complication of nonspecific ulcerative colitis. Surgery 1951; 30: 573-7.
91. Ricketts WE, Kirsner JB, Rothman S,. Pyoderma gangrenosum in chronic non-specific ulcerative colitis; a report of three cases. Am J Med 1948; 5: 69-75.
92. Altieri M, Vaziri K, Orkin BA,. Topical tacrolimus for parastomal pyoderma gangrenosum: a report of two cases. Ostomy Wound Manage 2010; 56: 56-9.
93. Eaton PA, Callen JP,. Mycophenolate mofetil as therapy for pyoderma gangrenosum. Arch Dermatol 2009; 145: 781-5.
94. Perry HO,. Pyoderma gangrenosum. South Med J 1969; 62: 899-908.
95. Hong J-B, Su Y-N, Chiu H-C,. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2BP1 gene. J Am Acad Dermatol 2009; 61: 533-5.
96. Powell FC, Schroeter AL, Su WP, Perry HO,. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985; 55: 173-86.
97. Prystowsky JH, Kahn SN, Lazarus GS,. Present status of pyoderma gangrenosum. Review of 21 cases. Arch Dermatol 1989; 125: 57-64.
98. Tjandra JJ, Hughes LE,. Parastomal pyoderma gangrenosum in inflammatory bowel disease. Dis Colon Rectum 1994; 37: 938-42.
99. Von den Driesch P,. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 1997; 137: 1000-5.
100. Bennett ML, Jackson JM, Jorizzo JL, et al,. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 2000; 79: 37-46.
101. Mlika RB, Riahi I, Fenniche S, et al,. Pyoderma gangrenosum: a report of 21 cases. Int J Dermatol 2002; 41: 65-8.
102. Shankar S, Sterling JC, Rytina E,. Pustular pyoderma gangrenosum. Clin Exp Dermatol 2003; 28: 600-3.
103. Hasselmann DO, Bens G, Tilgen W, Reichrath J,. Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature. J Dtsch Dermatol Ges 2007; 5: 560-4.
104. Yüksel I, Ataseven H, Başar O, et al,. Peripheral arthritis in the course of inflammatory bowel diseases. Dig Dis Sci 2011; 56: 183-7.
105. Cairns BA, Herbst CA, Sartor BR, et al,. Peristomal pyoderma gangrenosum and inflammatory bowel disease. Arch Surg 1994; 129: 769-72.
106. Funayama Y, Kumagai E, Takahashi K-I, et al,. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease. Dis Colon Rectum 2009; 52: 311-14.
107. Ampuero J, Rojas-Feria M, Castro-Fernández M, et al,. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease. J Gastroenterol Hepatol 2014; 29: 291-5.
108. Trikudanathan G, Venkatesh PGK, Navaneethan U,. Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Drugs 2012; 72: 2333-49.
109. Ciccacci C, Biancone L, Di Fusco D, et al,. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease. J Crohns Colitis 2013; 7: 44-52.
110. Hov JR, Keitel V, Schrumpf E, et al,. TGR5 sequence variation in primary sclerosing cholangitis. Dig Dis 2011; 29: 78-84.
111. Hoff N-P, Gerber PA,. Pyoderma gangrenosum associated with chronic polyarthritis. CMAJ 2011; 183: 1746.
112. Holt PJ, Davies MG, Saunders KC, Nuki G,. Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore) 1980; 59: 114-33.
113. Lazarus GS, Goldsmith LA, Rocklin RE, et al,. Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis. Arch Dermatol 1972; 105: 46-51.
114. Palferman T, Colver G, Doyle D, et al,. Pyoderma gangrenosum and seronegative erosive polyarthritis. Arthritis Rheum 1983; 26: 813-14.
115. Porteau-Cassard L, Marc V, Dromer C, Fournié B,. Polyarthritis with perinuclear antineutrophil cytoplasmic antibody and Pyoderma gangrenosum. Report of a case. Rev Rhum Engl Ed 1997; 64: 847-8.
116. Seitz CS, Berens N, Bröcker E-B, Trautmann A,. Leg ulceration in rheumatoid arthritis-an underreported multicausal complication with considerable morbidity: analysis of thirty-six patients and review of the literature. Dermatology 2010; 220: 268-73.
117. English JS, Fenton DA, Barth J, et al,. Pyoderma gangrenosum and leucocytoclastic vasculitis in association with rheumatoid arthritis-a report of two cases. Clin Exp Dermatol 1984; 9: 270-6.
118. Stolman LP, Rosenthal D, Yaworsky R, Horan F,. Pyoderma gangrenosum and rheumatoid arthritis. Arch Dermatol 1975; 111: 1020-3.
119. Wilson-Jones E, Winkelmann RK,. Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum. J Am Acad Dermatol 1988; 18: 511-21.
120. Olivieri I, Costa AM, Cantini F, et al,. Pyoderma gangrenosum in association with undifferentiated seronegative spondylarthropathy. Arthritis Rheum 1996; 39: 1062-5.
121. Hastier P, Caroli-Bosc FX, Bartel HR, et al,. Pyoderma gangrenosum with hepatopancreatic manifestations in a patient with rheumatoid arthritis. Dig Dis Sci 1996; 41: 594-7.
122. Nordstrom D,. Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis. J Rheumatol 1995; 22: 1000-1.
123. Hughes JR, Smith E, Higgins EM, et al,. Pyoderma gangrenosum in a patient with rheumatoid arthritis responding to treatment with cyclosporin A. Br J Rheumatol 1994; 33: 680-1.
124. Cinotti E, Labeille B, Perrot JL, et al,. Certolizumab for the treatment of refractory disseminated pyoderma gangrenosum associated with rheumatoid arthritis. Clin Exp Dermatol 2014; 39: 750-1.
125. Ohashi T, Miura T, Yamamoto T,. Auricular pyoderma gangrenosum with penetration in a patient with rheumatoid arthritis. Int J Rheum Dis 2014; DOI: 10.1111/1756-185X.12411 [Epub ahead of print].
126. Hasegawa M, Nagai Y, Sogabe Y, et al,. Clinical analysis of leg ulcers and gangrene in rheumatoid arthritis. J Dermatol 2013; 40: 949-54.
127. Chia HY, Tang MB,. Chronic leg ulcers in adult patients with rheumatological diseases-a 7-year retrospective review. Int Wound J 2014; 11: 601-4.
128. Ayres S, Ayres S,. Pyoderma gangrenosum with an unusual syndrome of ulcers, vesicles, and arthritis. AMA Arch Derm 1958; 77: 269-78.
129. Tada M, Nakanishi T, Hirata C, et al,. Use of infliximab in a patient with pyoderma gangrenosum and rheumatoid arthritis. Mod Rheumatol 2010; 20: 598-601.
130. Stichenwirth M, Riedl E, Pehamberger H, Tappeiner G,. Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon? Arch Dermatol 2008; 144: 817-18.
131. Vandevyvere K, Luyten FP, Verschueren P, et al,. Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis. Clin Rheumatol 2007; 26: 2205-6.
132. Disla E, Quayum B, Cuppari GG, Pancorbo R,. Successful use of etanercept in a patient with pyoderma gangrenosum complicating rheumatoid arthritis. J Clin Rheumatol 2004; 10: 50-2.
133. Yayli S, Bahadir S, Alpay K, et al,. Pyoderma gangrenosum in association with juvenile rheumatoid arthritis. J Dermatol 2005; 32: 827-30.
134. Charles CA, Bialy TL, Falabella AF, et al,. Poor prognosis of arthritis-associated pyoderma gangrenosum. Arch Dermatol 2004; 140: 861-4.
135. Magro CM, Crowson AN,. The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. J Cutan Pathol 2003; 30: 1-10.
136. Spangler JG,. Pyoderma gangrenosum in a patient with psoriatic arthritis. J Am Board Fam Pract 2001; 14: 466-9.
137. Fukuhara K, Urano Y, Kimura S, et al,. Pyoderma gangrenosum with rheumatoid arthritis and pulmonary aseptic abscess responding to treatment with dapsone. Br J Dermatol 1998; 139: 556-8.
138. Van der Sluis I,. Two cases of pyoderma (ecthyma) gengraenosum associated with the presence of an abnormal serumprotein (beta-2-A-paraprotein). With a review of the literature. Dermatologica 1966; 132: 409-24.
139. Claudy AL, Gogue Y, Volle H,. [Pyoderma gangrenosum associated with seronegative polyarthritis. Report of a case. Review of the literature (author's transl.)]. Ann Dermatol Venereol 1978; 105: 701-4 (in French).
140. Duguid CM, O'Loughlin S, Otridge B, Powell FC,. Paraneoplastic pyoderma gangrenosum. Australas J Dermatol 1993; 34: 17-22.
141. Hay CR, Messenger AG, Cotton DW, et al,. Atypical bullous pyoderma gangrenosum associated with myeloid malignancies. J Clin Pathol 1987; 40: 387-92.
142. Jacobs P, Palmer S, Gordon-Smith EC,. Pyoderma gangrenosum in myelodysplasia and acute leukaemia. Postgrad Med J 1985; 61: 689-94.
143. Perry HO, Winkelmann RK,. Bullous pyoderma gangrenosum and leukemia. Arch Dermatol 1972; 106: 901-5.
144. Powell FC, Schroeter AL, Su WP, Perry HO,. Pyoderma gangrenosum and monoclonal gammopathy. Arch Dermatol 1983; 119: 468-72.
145. Sung C-C, Chang P-Y, Wu Y-Y, et al,. Pyoderma gangrenosum as initial presentation of chronic myelomonocytic leukemia. Eur J Haematol 2009; 82: 410.
146. Koca E, Duman AE, Cetiner D, et al,. Successful treatment of myelodysplastic syndrome-induced pyoderma gangrenosum. Neth J Med 2006; 64: 422-4.
147. Goto A, Yamamoto S, Notoya A, et al,. Pyoderma gangrenosum complicated with myelodysplastic syndrome followed by rapidly progressing pyothorax-associated lymphoma: a case report. Hokkaido Igaku Zasshi 2006; 81: 261-4.
148. Yoshida C, Kojima H, Ishigaki T, et al,. Association of pyoderma gangrenosum and sterile osteomyelitis in a patient having myelodysplastic syndrome with der(1;7)(q10;q10). Eur J Haematol 2004; 72: 149-53.
149. Yates P, Corbett G, Stockdill G,. Pyoderma gangrenosum and myelodysplasia. Clin Lab Haematol 1987; 9: 425-8.
150. Chang C-M, Hwang W-L, Hsieh Z-Y, et al,. Monoclonal gammopathy of undetermined significance related pyoderma gangrenosum successfully treated with autologous peripheral blood stem cell transplantation. Ann Hematol 2010; 89: 823-4.
151. Wayte JA, Rogers S, Powell FC,. Pyoderma gangrenosum, erythema elevatum diutinum and IgA monoclonal gammopathy. Australas J Dermatol 1995; 36: 21-3.
152. Mijuşkovic ZP, Zecevic RD, Pavlovic MD,. Pyoderma gangrenosum with spleen involvement and monoclonal IgA gammopathy. J Eur Acad Dermatol Venereol 2004; 18: 697-9.
153. Matsubara K, Isoda K, Maeda Y, Mizutani H,. Pyoderma gangrenosum associated with paroxysmal nocturnal hemoglobulinuria and monoclonal gammopathy. J Dermatol 2002; 29: 86-90.
154. Möller H, Waldenström JG, Zettervall O,. Pyoderma gangraenosum (dermatitis ulcerosa) and monoclonal (IgA) globulin healed after melphalan treatment. Case report and review of the literature. Acta Med Scand 1978; 203: 293-6.
155. Cream JJ,. Pyoderma gangrenosum with a monoclonal IgM red cell agglomerating factor. Br J Dermatol 1971; 84: 223-6.
156. Fox LP, Geyer AS, Husain S, Grossman ME,. Bullous pyoderma gangrenosum as the presenting sign of fatal acute myelogenous leukemia. Leuk Lymphoma 2006; 47: 147-50.
157. Jacobson S, Martin DB, Deng A, Cooper JZ,. Pyoderma gangrenosum following tattoo placement in a patient with acute myelogenous leukemia. J Dermatolog Treat 2008; 19: 58-60.
158. Ayyala RS, Armstrong S,. Corneal melting and scleromalacia perforans in a patient with pyoderma gangrenosum and acute myeloid leukemia. Ophthalmic Surg Lasers 1998; 29: 328-31.
159. Beele H, Verhaeghe E, Stockman A, et al,. Pyoderma gangrenosum as an early revelator of acute leukemia. Dermatology 2000; 200: 176-8.
160. Asai M, Aragane Y, Kawada A, et al,. Pyoderma gangrenosum associated with biphenotypic acute leukemia. J Am Acad Dermatol 2001; 44: 530-1.
161. Hayani A, Steuber CP, Mahoney DH, Levy ML,. Pyoderma gangrenosum in childhood leukemia. Pediatr Dermatol 1990; 7: 296-8.
162. Gilman AL, Cohen BA, Urbach AH, Blatt J,. Pyoderma gangrenosum as a manifestation of leukemia in childhood. Pediatrics 1988; 81: 846-8.
163. Montoto S, Bosch F, Estrach T, et al,. Pyoderma gangrenosum triggered by alpha2b-interferon in a patient with chronic granulocytic leukemia. Leuk Lymphoma 1998; 30: 199-202.
164. Rogalski C, Paasch U, Glander H-J, Haustein U-F,. Bullous pyoderma gangrenosum complicated by disseminated intravascular coagulation with subsequent myelodysplastic syndrome (chronic myelomonocytic leukemia). J Dermatol 2003; 30: 59-63.
165. Schlick K, Regauer S, Beham-Schmid C, et al,. Pyoderma gangrenosum heralding acute leukemia for months: diagnostic hint written on the skin. J Clin Oncol 2011; 29: e506-8.
166. Bakhshi S, Sethuraman G, Singh MK, Arya LS,. Atypical pyoderma gangrenosum as a manifestation of childhood acute lymphoblastic leukemia. Pediatr Dermatol 2005; 22: 543-5.
167. Kitahama A, Roland PY, Kerstein MD,. Pyoderma gangrenosum with cutaneous T-cell lymphoma manifested as lower extremity ulcers-case reports. Angiology 1991; 42: 498-503.
168. Török L, Kirschner A, Gurzõ M, Krenács L,. Bullous pyoderma gangrenosum as a manifestation of leukemia cutis. Eur J Dermatol 2000; 10: 463-5.
169. Tamaki K, Nakazawa T, Mamehara A, et al,. Successful treatment of pyoderma gangrenosum associated with myelodysplastic syndrome using high-dose intravenous immunoglobulin. Intern Med 2008; 47: 2077-81.
170. Yamauchi T, Ishida K, Iwashima Y, et al,. Successful treatment of pyoderma gangrenosum that developed in a patient with myelodysplastic syndrome. J Infect Chemother 2003; 9: 268-71.
171. Braun-Falco M, Stock K, Ring J, Hein R,. Topical platelet-derived growth factor accelerates healing of myelodysplastic syndrome-associated pyoderma gangrenosum. Br J Dermatol 2002; 147: 829-31.
172. Kohl PK, Hartschuh W, Tilgen W, Frosch PJ,. Pyoderma gangrenosum followed by subcorneal pustular dermatosis in a patient with IgA paraproteinemia. J Am Acad Dermatol 1991; 24: 325-8.
173. Hensley CD, Caughman SW,. Neutrophilic dermatoses associated with hematologic disorders. Clin Dermatol 2000; 18: 355-67.
174. Federman GL, Federman DG,. Recalcitrant pyoderma gangrenosum treated with thalidomide. Mayo Clin Proc 2000; 75: 842-4.
175. Hecker MS, Lebwohl MG,. Recalcitrant pyoderma gangrenosum: treatment with thalidomide. J Am Acad Dermatol 1998; 38: 490-1.
176. Rustin MH, Gilkes JJ, Robinson TW,. Pyoderma gangrenosum associated with Behçet's disease: treatment with thalidomide. J Am Acad Dermatol 1990; 23: 941-4.
177. Wu JJ, Huang DB, Pang KR, et al,. Thalidomide: dermatological indications, mechanisms of action and side-effects. Br J Dermatol 2005; 153: 254-73.
178. Hayashi K, Hattori K, Toi F,. Thalidomide is a highly effective treatment of MDS: a single-hospital experience in Japan. Int J Hematol 2010; 91: 725-7.
179. Musto P,. Thalidomide therapy for myelodysplastic syndromes: current status and future perspectives. Leuk Res 2004; 28: 325-32.
180. Demidowich AP, Freeman AF, Kuhns DB, et al,. Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum 2012; 64: 2022-7.
181. Lee H, Park SH, Kim SK, et al,. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) with E250K mutation in CD2BP1 gene treated with the tumor necrosis factor inhibitor adalimumab. Clin Exp Rheumatol 2012; 30: 452.
182. Nesterovitch AB, Hoffman MD, Simon M, et al,. Mutations in the PSTPIP1 gene and aberrant splicing variants in patients with pyoderma gangrenosum. Clin Exp Dermatol 2011; 36: 889-95.
183. Wang T, Matukas L, Streutker CJ,. Histologic findings and clinical characteristics in acutely symptomatic ulcerative colitis patients with superimposed Clostridium difficile infection. Am J Clin Pathol 2013; 140: 831-7.
184. Wise CA, Gillum JD, Seidman CE, et al,. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 2002; 11: 961-9.
185. Yeon HB, Lindor NM, Seidman JG, Seidman CE,. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet 2000; 66: 1443-8.
186. Tallon B, Corkill M,. Peculiarities of PAPA syndrome. Rheumatology (Oxford) 2006; 45: 1140-3.
187. Lindor NM, Arsenault TM, Solomon H, et al,. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 1997; 72: 611-15.
188. Marzano AV, Trevisan V, Gattorno M, et al,. Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. JAMA Dermatol 2013; 149: 762-4.
189. Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T,. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)-a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol 2012; 66: 409-15.
190. Brenner M, Ruzicka T, Plewig G, et al,. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol 2009; 161: 1199-201.
191. Fathalla BM, Al-Wahadneh AM, Al-Mutawa M, et al,. A novel de novo PSTPIP1 mutation in a boy with pyogenic arthritis, pyoderma gangrenosum, acne (PAPA) syndrome. Clin Exp Rheumatol 2014; 32: 956-8.
192. Lambertucci JR,. Fever of undetermined origin in a patient with pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA syndrome). Rev Soc Bras Med Trop 2014; 47: 122.
193. Geusau A, Mothes-Luksch N, Nahavandi H, et al,. Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment. JAMA Dermatol 2013; 149: 209-15.
194. Edrees AF, Kaplan DL, Abdou NI,. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) associated with hypogammaglobulinemia and elevated serum tumor necrosis factor-alpha levels. J Clin Rheumatol 2002; 8: 273-5.
195. Stichweh DS, Punaro M, Pascual V,. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatr Dermatol 2005; 22: 262-5.
196. Wang D, Höing S, Patterson HC, et al,. Inflammation in mice ectopically expressing human Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne (PAPA) Syndrome-associated PSTPIP1 A230T mutant proteins. J Biol Chem 2013; 288: 4594-601.
197. Shoham NG, Centola M, Mansfield E, et al,. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci USA 2003; 100: 13501-6.
198. Waite AL, Schaner P, Richards N, et al,. Pyrin modulates the intracellular distribution of PSTPIP1. PLoS One 2009; 4: e6147.
199. Hsiao JL, Antaya RJ, Berger T, et al,. Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review. Arch Dermatol 2010; 146: 1265-70.
200. Marzano AV, Ishak RS, Colombo A, et al,. Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery. Dermatology 2012; 225: 215-19.
201. Palanivel JA, Macbeth AE, Levell NJ,. Pyoderma gangrenosum in association with Janus kinase 2 (JAK2V617F) mutation. Clin Exp Dermatol 2013; 38: 44-6.
202. Hideki M, Tetsurou T, Sakae F, et al,. Idiopathic myelofibrosis and pyoderma gangrenosum involving a mutation of Janus kinase 2 (JAK2V617F), showing poor prognosis. Eur J Dermatol 2013; 23: 256-7.
203. ®). J Foot Ankle Surg 2013; 52: 781-5.
204. Crittenden SC, Gilbert JE, Callen JP,. Hydroxyurea-induced leg ulceration in a patient with a homozygous MTHFR polymorphism misdiagnosed as pyoderma gangrenosum. JAMA Dermatol 2014; 150: 780-1.
205. New D, Eaton P, Knable A, Callen JP,. The use of B vitamins for cutaneous ulcerations mimicking pyoderma gangrenosum in patients with MTHFR polymorphism. Arch Dermatol 2011; 147: 450-3.
206. Rubio-González B, Castellanos-González M, Alegría-Landa V, et al,. Skin ulcers mimicking pyoderma gangrenosum in a patient with MTHFR polymorphism. J Am Acad Dermatol 2012; 67: e282-4.
207. al-Rimawi HS, Abuekteish FM, Daoud AS, Oboosi MM,. Familial pyoderma gangrenosum presenting in infancy. Eur J Pediatr 1996; 155: 759-62.
208. Alberts JH, Sams HH, Miller JL, King LE Jr,. Familial ulcerative pyoderma gangrenosum: a report of 2 kindred. Cutis 2002; 69: 427-30.
209. Boussofara L, Gammoudi R, Ghariani N, et al,. Familial pyoderma gangrenosum in association with common variable immunodeficiency. Br J Dermatol 2013; 169: 944-6.
210. Khandpur S, Mehta S, Reddy BS,. Pyoderma gangrenosum in two siblings: a familial predisposition. Pediatr Dermatol 2001; 18: 308-12.
211. Shands JW Jr, Flowers FP, Hill HM, Smith JO,. Pyoderma gangrenosum in a kindred. Precipitation by surgery or mild physical trauma. J Am Acad Dermatol 1987; 16: 931-4.
212. Girardin C, Salagnac V, Léonard F, et al,. [Postoperative and post-traumatic familial pyoderma gangrenosum]. Ann Dermatol Venereol 1988; 115: 1149-51 (in French).